Adaptive Biotechnologies (ADPT) Tops Q3 EPS by 7c ; Offers Guidance
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $24.41 -2.05%
Revenue Growth %: -23.8%
Financial Fact:
Operating loss: -32.21M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Revenue Growth %: -23.8%
Financial Fact:
Operating loss: -32.21M
Today's EPS Names:
PMCB, PLCE, DOMO, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q3 EPS of ($0.22), $0.07 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $46.4 million versus the consensus estimate of $40.21 million.
GUIDANCE:
Adaptive Biotechnologies sees FY2024 revenue of $143-145 million, versus the consensus of $172.1 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- PG&E Corp, Edison spike on chatter
- Anthropic launches Enterprise Frontier Safeguards for Claude
- Apple new CEO Ternus teases "phenomenal" iPhone launch in first memo
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
